Moreover, leveraging transferrin receptor-mediated delivery pathways, as evidenced in brain delivery and cancer targeting studies 64, 65, suggests that oAd5/3-TBD-GFP may enhance tumor selectivity. Here, TFRC is linked to neoplasm.